Clinical trial

Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients…

NCT00268437 · Alliance for Clinical Trials in Oncology, Other · Terminated

Key facts

NCT number NCT00268437
Title Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
Official title A Phase II Trial of Preoperative Radiation and Chemotherapy (Pemetrexed and Carboplatin) for Locally Advanced Esophageal Cancer
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Esophageal Cancer
Intervention type Drug, Procedure, Radiation
Interventions carboplatin, Pemetrexed, conventional surgery, neoadjuvant therapy, radiation therapy
Enrollment 27
Start date Apr 1, 2006
Primary completion Jan 1, 2008
Completion Mar 1, 2015
First posted Dec 22, 2005
Last update posted Jul 6, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies